0001415889-23-002459.txt : 20230214
0001415889-23-002459.hdr.sgml : 20230214
20230214164636
ACCESSION NUMBER: 0001415889-23-002459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230210
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fernandes Peter
CENTRAL INDEX KEY: 0001642618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 23630791
MAIL ADDRESS:
STREET 1: PERRYVILLE III CORPORATE PARK
STREET 2: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
form4-02142023_040200.xml
X0306
4
2023-02-10
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001642618
Fernandes Peter
184 LIBERTY CORNER RD.
SUITE 302
WARREN
NJ
07059
false
true
false
false
CHIEF EXECUTIVE OFFICER
Stock Options (right to buy)
1.52
2023-02-10
4
A
0
100000
1.52
A
2033-02-10
Common Stock
100000
100000
D
This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.
/s/ Peter Fernandes
2023-02-14